Accessibility Menu
China Medicine logo

China Medicine

(OTC) CHME

Current Price$0.02
Market Cap$487.90K
Since IPO (2006)-99%
5 Year-69%
1 Year+6,733%
1 Month+3%

China Medicine Financials at a Glance

Market Cap

$487.90K

Revenue (TTM)

$65.75M

Net Income (TTM)

$6.03M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-9.20 (Low)

Price

$0.02

Volume

25,900

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.00 - $0.04

Estimated Earnings Date

Nov 9, 2022

CHME News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About China Medicine

Industry

Pharmaceuticals

Headquarters

Guangzhou, NY 510006, CN

CHME Financials

Key Financial Metrics (TTM)

Gross Margin

29.32%

Operating Margin

18.94%

Net Income Margin

2.65%

Return on Equity

3.91%

Return on Capital

22.51%

Return on Assets

2.57%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$487.90K

Shares Outstanding

23.80M

Volume

25.90K

Avg. Volume

3.91K

Financials (TTM)

Gross Profit

$22.00M

Operating Income

$11.70M

EBITDA

$13.41M

Operating Cash Flow

$11.01M

Capital Expenditure

-$4.58M

Free Cash Flow

$6.43M

Cash & ST Invst.

$7.85M

Total Debt

$3.20M

China Medicine Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2010YOY CHG

Revenue

$17.55M

-8.4%

Gross Profit

$5.80M

-0.5%

Gross Margin

33.07%

N/A

Market Cap

$487.90K

N/A

Market Cap/Employee

$1.74K

N/A

Employees

281

N/A

Net Income

$2.22M

-31.0%

EBITDA

$2.91M

-39.0%

Quarterly Fundamentals

Name
Q3 2010YOY CHG

Total Cash

$7.85M

+250.2%

Total Debt

$3.20M

+9.1%

Accounts Receivable

$17.27M

+2.5%

Inventory

$5.87M

-26.2%

Long Term Debt

$0.00

N/A

Short Term Debt

$3.20M

+9.1%

Return on Assets

2.57%

N/A

Return on Invested Capital

23.40%

N/A

Free Cash Flow

-$4.78M

-337.8%

Operating Cash Flow

-$346.56K

-117.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PPJEPPJ Healthcare Enterprises, Inc.
$0.00+0.00%
DTRKDATATRAK International, Inc.
$0.18+0.00%
CTTHCTT Pharmaceutical Holdings, Inc.
$0.08+0.00%
PCYNProcyon Corporation
$0.20+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.92-0.01%
TAT&T
$20.58+0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%
CLROClearOne
$6.48+1.01%

Questions About CHME

What is the current price of China Medicine?

China Medicine is trading at $0.02 per share.

What is the 52-week range for China Medicine?

Over the past 52 weeks, China Medicine has traded between $0.00 and $0.04.

How much debt does China Medicine have?

China Medicine total debt is unavailable.

How much cash does China Medicine have on hand?

China Medicine does not have cash on hand data available.

What is China Medicine’s dividend yield?

China Medicine does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.